Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NDA submitted for Eligard 30 mg for advanced prostate cancer

April 18, 2002

Trial initiated for Reolysin in prostate cancer

April 18, 2002

Xcytrin to enter confirmatory phase III trial in lung cancer patients

April 18, 2002

VEGFR tyrosine kinase inhibitor enters clinical testing based on preclinical results

April 18, 2002

Prolifix identifies hydroxamate-based inhibitors of HDAC with antitumor activity

April 18, 2002

Euroscreen acquires license to hormone receptor technology

April 18, 2002

Orally active VEGFR tyrosine kinase inhibitor RWJ-417975 exerts antitumor activity in mouse models

April 18, 2002

Estrogen receptor modulators and their use described by Akzo Nobel team

April 17, 2002

AVI-4126 may be useful alone or in combination in the treatment of prostate cancer

April 17, 2002

Semisynthetic andrographolide analogue with immunomodulating and antitumor activity

April 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...